Concept:
The clinical scenario describes an adolescent female presenting with a combination of endocrine abnormalities and visual disturbances.
The constellation of short stature, delayed puberty, and primary amenorrhea indicates a deficiency in anterior pituitary hormones (growth hormone and gonadotropins).
The concurrent bilateral optic atrophy and reduced visual acuity point toward a significant compressive lesion in the suprasellar region affecting the optic chiasm or optic nerves.
Explanation:
• Craniopharyngiomas are benign, slow-growing tumors arising from remnants of Rathke's pouch.
• They typically present in a bimodal age distribution, with peaks in childhood or adolescence (5-14 years) and adulthood (50-74 years).
• Due to their suprasellar location, they cause mass effect on the surrounding structures, leading to a classic triad of symptoms: visual field defects, endocrine dysfunction, and features of raised intracranial pressure.
• Chronic compression of the optic pathway can lead to bilateral optic atrophy, manifesting as severely reduced visual acuity.
• Endocrinologically, the compression of the pituitary stalk or the pituitary gland itself leads to panhypopituitarism.
• Growth hormone deficiency causes short stature, which is a hallmark presentation in affected children and adolescents.
• Gonadotropin deficiency (LH and FSH) results in delayed puberty and primary amenorrhea in a 17-year-old female.
• A HESX1 mutation causes septo-optic dysplasia (De Morsier syndrome), which is congenital and typically presents in infancy with hypoglycemia, seizures, and midline brain defects, rather than newly presenting in a 17-year-old.
• Pituitary adenomas in this age group are usually prolactinomas, which cause amenorrhea but are less likely to cause such profound short stature and bilateral optic atrophy without earlier detection.
• Rathke's cleft cysts are mostly asymptomatic and rarely cause such severe combined neuro-ophthalmic and panhypopituitary symptoms.
Final answer:
The most probable diagnosis integrating all clinical findings in this age group is Craniopharyngioma.